Company
Coopervision
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
9
510(k), De Novo and PMA
Device trials
175
As lead sponsor, any status
Adverse event reports
86
Received Nov 1, 2025 to Nov 20, 2026
Recall records
40
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Coopervision, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Coopervision.
Latest FDA decisions
The 8 newest of 9 since 2015.
K234127 · Decided Jan 25, 2024 · 28 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
K220070 · Decided Feb 4, 2022 · 25 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
- Avaira Vitality510(k)
K213164 · Decided Oct 26, 2021 · 28 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
6 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Title: Clinical Performance and Outcomes After Sphere Lens TransitionNot yet recruiting
NCT07940426 · 36 participants (planned) · Start Nov 2026 · Primary completion Feb 2027
Device: Fanfilcon A sphere Contact lens · For: Astigmatism
Sites: México, Mexico
- Clinical Performance and Outcomes After Toric Lens TransitionNot yet recruiting
NCT07898995 · 35 participants (planned) · Start Nov 2026 · Primary completion Feb 2027
Device: Fanfilcon A Toric Contact Lens · For: Astigmatism
Sites: Bloomington, Indiana
NCT07829419 · 60 participants (planned) · Start Nov 2, 2026 · Primary completion Sep 2027
Device: Lens A ( comfilcon A); Lens B ( lehfilcon A) · For: Astigmatism; Myopia
Sites: New York, New York; Granville, Ohio; Corpus Christi, Texas
172 more trials with a free account
Reports received
86
Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.
Malfunction reports
4
4.7% of reports
Injury reports
81
94% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 17 | 0 | 0 |
| Jan 24 | 0 | 7 | 0 | 0 |
| Feb 24 | 1 | 11 | 0 | 0 |
| Mar 24 | 0 | 13 | 0 | 0 |
| Apr 24 | 0 | 4 | 0 | 0 |
| May 24 | 0 | 8 | 0 | 0 |
| Jun 24 | 0 | 15 | 0 | 0 |
| Jul 24 | 0 | 7 | 0 | 0 |
| Aug 24 | 0 | 14 | 0 | 0 |
| Sep 24 | 0 | 10 | 0 | 0 |
| Oct 24 | 0 | 8 | 0 | 0 |
| Nov 24 | 0 | 6 | 0 | 0 |
| Dec 24 | 0 | 4 | 0 | 0 |
| Jan 25 | 2 | 4 | 0 | 0 |
| Feb 25 | 0 | 8 | 0 | 0 |
| Mar 25 | 1 | 10 | 0 | 0 |
| Apr 25 | 0 | 3 | 0 | 0 |
| May 25 | 0 | 2 | 0 | 0 |
| Jun 25 | 0 | 7 | 0 | 0 |
| Jul 25 | 0 | 7 | 0 | 0 |
| Aug 25 | 0 | 3 | 0 | 0 |
| Sep 25 | 0 | 12 | 0 | 0 |
| Oct 25 | 0 | 6 | 0 | 0 |
| Nov 25 | 1 | 3 | 0 | 0 |
| Dec 25 | 0 | 7 | 0 | 0 |
| Jan 26 | 0 | 5 | 0 | 0 |
| Feb 26 | 0 | 14 | 0 | 0 |
| Mar 26 | 0 | 9 | 0 | 0 |
| Apr 26 | 2 | 3 | 0 | 0 |
| May 26 | 0 | 5 | 0 | 0 |
| Jun 26 | 0 | 8 | 0 | 0 |
| Jul 26 | 0 | 6 | 0 | 0 |
| Aug 26 | 0 | 4 | 0 | 1 |
| Sep 26 | 1 | 7 | 0 | 0 |
| Oct 26 | 0 | 10 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
3 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0204-2027 · Started Sep 22, 2026 · Posted by FDA Oct 22, 2026
Reason given: The affected products bear an incorrect statement on the carton packaging indicating that the product is "Indicated for Extended Wear". However, this product is intended for daily wear, and the extended-wear statement should not have appeared on the affected carton labeling. This product is not approved by the U.S....
Cause as FDA categorized it: Labeling design · Device type: Lenses, Soft Contact, Daily Wear (LPL)
- Brand Name: Pearle Vision 1 day Product Name: (somofilcon A) Contact Lens Model/Catalog Number: Pearle Vision 1 dayOpen, Classified
Z-3248-2026 · Started Aug 12, 2026 · Posted by FDA Sep 18, 2026
Reason given: A small number of lenses within the affected lot are of the incorrect power.
Cause as FDA categorized it: Process control · Device type: Lens, Contact, (Disposable) (MVN)
Z-2606-2025 · Started Aug 22, 2025 · Posted by FDA Sep 19, 2025
Reason given: One lot manufactured with an invalid sterilization cycle.
Cause as FDA categorized it: Under Investigation by firm · Device type: Lens, Contact, (Disposable) (MVN)
37 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.